Pharmacyclics (PCYC) Inactive 10-K2008 FY Annual report

Filed: 5 Sep 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: Academy, advisor, agammaglobulinemia, allergic, antibody, antigen, AU, back, bank, Barbara, Bayer, BCR, Becton, biomarker, BioPharma, Bruton, Buggy, CA, Chair, characterized, Chimeric, China, Chirac, classification, Cleveland, collagen, computerized, Congressman, consecutive, CT, cytokine, delisted, Dentistry, Developmental, Dickinson, digital, discontinue, divide, DLCBL, Duggan, Dynavax, efficiently, encryption, escalation, executory, Fifteen, follicular, Foundation, GAAP, genetic, hardware, Haven, Honor, imagining, Immunocytometry, immunodeficiency, implicated, Indiana, inflammation, Intuitive, joint, Joseph, Journal, Knight, Legion, Lowder, mast, maximum, Medal, mediated, Merit, MGd, Microbiology, Monogram, Motion, mouse, mutation, NCI, NHL, nonfinancial, nongovernmental, nonrefundable, Northwestern, onset, outdoor, passive, pathology, PC, PCI, PDL, pipeline, Pittsburgh, probe, pronouncement, propensity, quoted, RA, reaction, receptor, recurring, regain, regained, regression, residency, retail, Robert, Santa, scientist, software, sparring, SRS, stem, sublicensing, suppressed, surface, swelling, thought, thrombotic, Univerity, unregistered, viablility, Western

Removed: Addendum, Adria, advancement, affiliated, announcement, Attorney, Austin, Bush, certification, chemical, close, commencement, committed, compensatory, Consent, consummation, Cook, dated, Division, Dixie, duly, elimination, England, enrolling, executed, failed, granting, holder, Indemnification, injection, intention, Involuntary, jointly, Junior, lawfully, Leiv, Lonza, Master, MEN, Metropolitan, Michigan, Mutual, netted, omitted, ratifying, Renschler, requested, Restated, resubstitution, rohn, segment, shareholder, signature, Specimen, stead, Stuart, substitute, substitution, Taxotere, tender, thereto, thereunto, therewith, thing, true, undersigned, user, versatility, virtue, visualized, WHEREOF, william, Young

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PCYC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)

In connection with the Annual Report of Pharmacyclics, Inc., a Delaware corporation (the "Company"), on Form 10-K for the year ending June 30, 2008 as filed with the Securities and Exchange Commission (the "Report"), I, Richard A. Miller, M.D., President and Chief Executive Officer of the Company, certify, pursuant to §906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350), that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/S/ RICHARD A. MILLER, M.D.

Richard A. Miller, M.D.
President and Chief Executive Officer
September 5, 2008

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)

In connection with the Annual Report of Pharmacyclics, Inc, a Delaware corporation (the "Company"), on Form 10-K for the year ending June 30, 2008 as filed with the Securities and Exchange Commission (the "Report"), I, Leiv Lea, Vice President, Finance and Administration and Chief Financial Officer of the Company, certify, pursuant to §906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350), that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/S/ LEIV LEA

Leiv Lea
Vice President, Finance and Administration
and Chief Financial Officer and Secretary
September 5, 2008

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.